ACTIVE

DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result142,3 k €+5,0 %over 1 year
Gross margin279,8 k €-4,4 %over 1 year
Equity1,3 M €+12,0 %over 1 year

Identity

Source · BCE/KBO

DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie is a Private limited company incorporated in 2008. Its main activity is: Specialist medical practice activities. Its registered office is in Zele.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0899.915.916
Incorporation
18/08/2008
Legal form
Private limited company
Registered office
Scheldestraat 113
9240 Zele · FlandreSee on map
Contributed capital
110 000,00 €
Latest accounts
30/06/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin279,8 k €292,8 k €304,7 k €260,3 k €
EBITDA275,5 k €282,7 k €297,6 k €255,4 k €
Operating result214,8 k €222,5 k €238,2 k €195,1 k €
Net result142,3 k €135,6 k €148,1 k €120,2 k €
Balance sheet
Equity1,3 M €1,2 M €1 M €901,5 k €
Total assets1,9 M €1,8 M €1,7 M €1,7 M €
Cash241,5 k €179,4 k €265 k €267,3 k €
Debts550,2 k €614,5 k €681,6 k €773 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Saskia ROBBRECHT
Bestuurdersince 20/11/2024Manager22/08/2008 → 22/08/2018endedDirectorended

Other companies at this address

Scheldestraat 113 9240 Zele
CompanyCBE no.
Claire● Active
0771.473.860

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date05/02/202630/01/202529/01/202425/01/202320/01/202227/01/2021
General meeting25/01/202622/01/202530/12/202331/12/202227/12/202126/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202525/01/202605/02/2026DutchPDF
Micro model30/06/202422/01/202530/01/2025DutchPDF
Micro model30/06/202330/12/202329/01/2024DutchPDF
Micro model30/06/202231/12/202225/01/2023DutchPDF
Micro model30/06/202127/12/202120/01/2022DutchPDF
Micro model30/06/202026/12/202027/01/2021DutchPDF
Micro model30/06/201928/12/201928/01/2020DutchPDF
Micro model30/06/201829/12/201829/01/2019DutchPDF
Micro model30/06/201730/12/201729/01/2018DutchPDF
Abridged model30/06/201631/12/201631/01/2017DutchPDF
Abridged model30/06/201526/12/201514/01/2016DutchPDF
Abridged model30/06/201427/12/201415/01/2015DutchPDF
Abridged model30/06/201328/12/201315/01/2014DutchPDF
Abridged model30/06/201229/12/201225/01/2013DutchPDF
Abridged model30/06/201131/12/201126/01/2012DutchPDF
Abridged model30/06/201027/12/201012/01/2011DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Saskia ROBBRECHT
Bestuurdersince 20/11/2024Manager22/08/2008 → 22/08/2018endedDirectorended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/01/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office09/06/2010
    BENAMING - MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other01/09/2008
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings4 filings
Mandates
Saskia ROBBRECHT
2008200920102011201220132014201520162017201820192020202120222023202420252026
DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie
Scheldestraat 113, 9240 Zele
BestuurderManager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Scheldestraat 113, 9240 ZeleCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00033213

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologieCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00033213

Events

  1. 2025
    Annual accounts 2025142,3 k €↑
  2. 2024
    Annual accounts 2024135,6 k €↓
  3. 2023
    Annual accounts 2023148,1 k €↑
  4. 2022
    Annual accounts 2022120,2 k €
  5. 18/08/2008
    IncorporationPrivate limited company